Generate Biomedicines, Inc. (GENB)

20.90 +3.18 (+17.95%) USD  |  NASDAQ  |  Aug 25, 11:13
More

Generate Biomedicines Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for GENB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2026. Start Trial.
Date Value
August 07, 2026 --
August 06, 2026 --
May 13, 2026 --
May 08, 2026 --
Date Value
May 07, 2026 --
April 13, 2026 --
April 02, 2026 --
March 24, 2026 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Twist Bioscience Corp. Upgrade
Prime Medicine, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade